Kelley A. Wendt
2012
In 2012, Kelley A. Wendt earned a total compensation of $220.2K as Chief Financial Officer at AmpliPhi Biosciences.
Compensation breakdown
| Option Awards | $100,000 |
|---|---|
| Other | $120,247 |
| Total | $220,247 |
Wendt received $120.2K in other compensation, accounting for 55% of the total pay in 2012.
Wendt also received $100K in option awards.
Rankings
In 2012, Kelley A. Wendt's compensation ranked 10,725th out of 11,487 executives tracked by ExecPay. In other words, Wendt earned more than 6.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,725 out of 11,487 | 7th |
Division Manufacturing | 3,992 out of 4,253 | 6th |
Major group Chemicals And Allied Products | 1,112 out of 1,198 | 7th |
Industry group Drugs | 851 out of 920 | 8th |
Industry Biological Products, Except Diagnostic Substances | 153 out of 160 | 4th |
Source: SEC filing on April 30, 2014.
Wendt's colleagues
We found two more compensation records of executives who worked with Kelley A. Wendt at AmpliPhi Biosciences in 2012.